|
|
 |
December 22, 2010
Corcept Therapeutics Announces Positive Phase 3 Study Results for CORLUX for the Treatment of Cushing's Syndrome
December 21, 2010
Jazz Pharmaceuticals Announces New Patent Issued for Sodium Oxybate
December 16, 2010
Amarin Completes Patient Randomization in Phase 3 ANCHOR Trial
December 13, 2010
Panasonic to Manufacture PixelOptics' Electronic Focusing Eyeglass Lens Blanks
November 29, 2010
Amarin’s AMR101 Meets Pivotal Phase 3 Study Endpoints
November 19, 2010
Xanodyne Pharmaceuticals, Inc. To Voluntarily Withdraw Darvon® and Darvocet-N® Products
October 18, 2010
Solta Medical To Acquire CLRS Technology
October 11, 2010
Jazz Pharmaceuticals Receives FDA Complete Response Letter Regarding JZP-6 for Treatment of Fibromyalgia
October 5, 2010
Jazz Pharmaceuticals Announces Paragraph IV ANDA Filing for Xyrem
September 16, 2010
Solta Medical Announces FDA 510(k) Clearance of Fraxel re:store Dual Laser System for the Treatment of Actinic Keratosis
August 30, 2010
Aptus Endosystems Completes $15 Million Series AA Financing
August 20, 2010
Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting for JZP-6 (sodium oxybate) in Fibromyalgia
August 10, 2010
Amarin’s AMR101 Pivotal Phase 3 MARINE Clinical Trial Completes Patient Enrollment and Randomization
August 6, 2010
Aptus Endosystems Completes First EndoStapling Procedures in Europe
July 1, 2010
Corcept Therapeutics Completes Enrollment in Phase 3 Cushing's Syndrome Study - Data Announcement Anticipated by Year End
June 30, 2010
Jazz Pharmaceuticals Announces Completion of Refinancing of its 15% Senior Secured Notes Due June 2011 with Closing of $50 Million Term Loan Due June 2013
June 30, 2010
Precision Therapeutics Growing Rapidly as it Augments Research and Development Efforts
June 29, 2010
AqueSys, Inc. Closes $35 Million Series C Round Led by Longitude Capital and Rho Ventures
June 25, 2010
Corcept Therapeutics Announces Pricing of $15 Million Underwritten Offering of Common Stock
June 17, 2010
$35 Million Investment Raised by Precision Therapeutics
May 11, 2010
Jazz Pharmaceuticals Announces Pricing of Public Offering of Common Stock
May 7, 2010
Xanodyne Announces Renewed Focus on Pain Management Market
May 3, 2010
Corcept Therapeutics Updates Cushing's Syndrome Development and Recent Financing
April 22, 2010
Corcept Therapeutics Announces Exercise of Existing Warrants and Private Placement of Warrants
April 1, 2010
Xanodyne and Ferring Announce Co-Promote for Zipsor
March 23, 2010
Corcept Therapeutics Initiates a Phase 1 Study of CORT 108297
March 19, 2010
PixelOptics Unveils Bold Marketplace Approach for Electronic Eyewear
February 23, 2010
Solta Medical to Acquire Aesthera Corporation
February 18, 2010
Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
January 11, 2010
Amarin Announces First Patients Enrolled in Two Phase 3 Clinical Trials for AMR101
January 8, 2010
Solta Medical to Raise $17.2 Million in Private Placement
January 5, 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
January 5, 2010
Panasonic Shikoku Electronics Joins PixelOptics in Development of Electronic Eye Glasses
|
|
|
